Precision MS Diagnostics Octave offers a multi-protein MS disease activity test (MSDA Test) that provides a quantitative trajectory view to inform clinical decisions, presenting a clear value proposition for neurology clinics, MS centers, and health systems seeking data-driven disease management solutions.

Clinical Partnerships Active collaboration with Quest Diagnostics and leading MS centers indicates a proven distribution and validation channel, suggesting sales opportunities through large lab networks and hospital systems that can scale adoption of the MSDA Test.

Digital Infrastructure A tech stack including AWS, Redshift and Salesforce enables scalable data integration, analytics, and CRM-driven outreach, enabling enterprise-grade deployment, multi-site expansion, and streamlined order-to-insight workflows for customers.

Geographic Footprint Headquartered in the Bay Area with national collaborations implies awareness and access to prominent West Coast health networks and nationwide MS care providers, presenting expansion opportunities across major U.S. markets.

Funding and Growth Momentum With mid-market revenue and substantial funding, Octave is positioned for scale investments in sales, clinical validation, and payer discussions, signaling potential for faster time-to-revenue through payer-ready value demonstrations and expanded product adoption.